KaydedilenlerDerginizi ekleyin

Dergiler / Eastern Journal of Medicine / 2016 / Cilt: 21 - Sayı: 3

Should antenatal corticosteroids be done after 34 weeks of gestation? Review article

SUNULLAH SOYSAL
BEGÜM YILDIZHAN
Sayfa
154–157
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In this review, need for antenatal corticosteroids after 34 weeks of gestation is studied.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Late preterm infants constitute the majority of preterm labors.
📊
Temel Bulgular & Veri:This arises the question of antenatal corticosteroid administration beyond 34 week of gestation.
💡
Sonuç & Katkı:In this review, need for antenatal corticosteroids after 34 weeks of gestation is studied.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Late preterm infants constitute the majority of preterm labors. The neonatal morbidity and mortality among late preterm infants are serious problems of obstetrical practice. This arises the question of antenatal corticosteroid administration beyond 34 week of gestation. In this review, need for antenatal corticosteroids after 34 weeks of gestation is studied.

🔖

Bu Makaleye Atıf Yap

SOYSAL, S., YILDIZHAN, B. (2016). Should antenatal corticosteroids be done after 34 weeks of gestation? Review article. Eastern Journal of Medicine, Cilt: 21 - Sayı: 3, 154–157. https://ajindex.com/articles/222601

Kaynakça (14)

  1. Saigal S, Doyle LW. An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet 2008; 371: 261-269
  2. Matthews TJ, Mac Dorman MF. Infant mortality statistics from the2010 period linked birth/infant death data set. Natl Vital Stat Rep 2013; 62: 1-26
  3. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972; 50: 515
  4. Roberts D, Dalziel S. Antenatal corticosteroids for acceleratingfetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006; (3): CD004454
  5. Hamvas A. Pathophysiology and management of respiratorydistress syndrome. In: Martin RJ, Fanaroff AA, Walsh MC, eds.Fanaroff and Martin's NeonatalPerinatal Medicine: Diseases ofthe Fetus and Infant. 9th ed. Philadelphia: Mosby/Elsevier; 2011: 1106- 1116
  6. Smolders-de Haas H, Neuvel J, Schmand B, et al. Physical development and medical history of children who were treated antenatally with corticosteroids to prevent respiratory distress syndrome: a 10- to 12- year follow-up. Pediatrics 1990; 86: 65-70
  7. Ballard PL, Ballard RA. Scientific basis and therapeutic regimens for use of antenatal glucocorticoids. Am J Obstet Gynecol 1995; 173:254- 262
  8. Ballard PL. Hormonal regulation of surfactant in fetal life. Mead Johnson Symp Perinat Dev Med 1978; 25- 39
  9. Walther FJ, David-Cu R, Mehta EI, et al. Higher lung antioxidant enzyme activity persists after single dose of corticosteroids in preterm lambs. Am J Physiol 1996; 271: 187-191
  10. Polk DH, Ikegami M, Jobe AH, et al. Preterm lung function after retreatment with antenatal betamethasone in preterm lambs. Am J Obstet Gynecol 1997; 176: 308-315
  11. Grier DG, Halliday HL. Effects of glucocorticoids on fetal and neonatal lung development. Treat Respir Med 2004; 3: 295-306
  12. O'Brodovich HM. Immature epithelial Na+ channel expression is one of the pathogenetic mechanisms leading to human neonatal respiratory distress syndrome. ProcAssoc Am Physicians 1996; 108:345- 355
  13. Brownfoot FC, Gagliardi DI, Bain E, Middleton P, Crowther CA. Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2013; 8:CD006764
  14. Bar-Lev MR, Maayan-Metzger A, Matok I, et al. Short-term outcomes in low birth weight infants following antenatal exposure to betamethasone versus dexamethasone. Obstet Gynecol 2004;